The Patent Finder

Great Lakes Neurotechnologies Inc.

Also on record
Records under this name other than the patents Great Lakes Neurotechnologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 51 patents it holds.

Back to Great Lakes Neurotechnologies Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,843,201Wearable, unsupervised transcranial direct current stimulation (tDCS) device for movement disorder therapy, and method of using
Lapsed on the fee record
Ended Sep 23, 2026 · High confidence
Lapsed on the fee recordEnded Sep 23, 2026High confidence
US 9,314,190Movement disorder recovery system and method
Term ended
Term ended May 11, 2026 · USPTO record
Term endedTerm ended May 11, 2026USPTO record
US 10,786,200Movement disorder drug or medication titration, delivery system, and method
Term ended
Term ended Mar 8, 2026 · USPTO record
Term endedTerm ended Mar 8, 2026USPTO record
US 10,750,946Parkinson's disease drug or medication titration, delivery system, and method
Term ended
Term ended Mar 1, 2026 · USPTO record
Term endedTerm ended Mar 1, 2026USPTO record
US 10,786,199Movement disorder continuous monitoring and therapy system
Term ended
Term ended Feb 23, 2026 · USPTO record
Term endedTerm ended Feb 23, 2026USPTO record
US 8,702,629Movement disorder recovery system and method for continuous monitoring
Term ended
Term ended Jan 6, 2026 · USPTO record
Term endedTerm ended Jan 6, 2026USPTO record
US 9,282,928Parkinson's disease drug or medication, titration, delivery system, and method
Term ended
Term ended Nov 25, 2025 · USPTO record
Term endedTerm ended Nov 25, 2025USPTO record
US 8,583,238Wearable, unsupervised transcranial direct current stimulation (tDCS) device for movement disorder therapy, and method of using
Lapsed on the fee record
Ended Nov 12, 2025 · High confidence
Lapsed on the fee recordEnded Nov 12, 2025High confidence
US 9,302,046Parkinson's disease continuous monitoring and therapy system
Term ended
Term ended Nov 5, 2025 · USPTO record
Term endedTerm ended Nov 5, 2025USPTO record
US 9,861,283Parkinson's disease drug or medication titration, delivery system, and method
Term ended
Term ended Sep 10, 2025 · USPTO record
Term endedTerm ended Sep 10, 2025USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited